Skip to main content
OpenTrials

Clinical trial condition

Hypercholesterolemia

Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

954 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hypercholesterolemia trial results

Completed

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

NCT00139178

Conditions
Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +25 more
Locations
  • Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark
  • Department of Infectious Diseases, Rigshospitalet Copenhagen, Denmark
  • Department of Infectious Diseases, Hvidovre University Hospital Hvidovre, Denmark
  • Department of Infectious diseases, Odense University Hospital Odense, Denmark
View Trial Details
Active, Not Recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

NCT05030428

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +9 more
Locations
  • UAB St Vincents Birmingham, Alabama, United States
  • Eastern Shore Research Institute Fairhope, Alabama, United States
  • G and L Research LLC Foley, Alabama, United States
  • Alaska Heart and Vascular Anchorage, Alaska, United States
View all 989 locations
View Trial Details
Active, Not Recruiting

Specified Drug-use Survey of Leqvio for s.c. Injection.

NCT06275724

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolaemia, +12 more
Locations
  • Novartis Investigative Site Handa, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Ichinomiya, Aichi-ken, Japan
  • Novartis Investigative Site Komaki, Aichi-ken, Japan
View all 107 locations
View Trial Details
Active, Not Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

NCT05739383

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Brain Diseases, +24 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • UAB St Vincents Birmingham, Alabama, United States
  • Eastern Shore Research Institute Fairhope, Alabama, United States
  • G and L Research LLC Foley, Alabama, United States
View all 986 locations
View Trial Details
Active, Not Recruiting

VIsualization of Coronary Artery Disease for Modification of RISK Factors

NCT06413641

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +12 more
Locations
  • Gødstrup Hospital Gødstrup, Jutland, Denmark
  • Aalborg University Hospital Aalborg, Denmark
  • Bjarne L Nørgaard Aarhus, Denmark
  • Hospital of South West Jutland Esbjerg, Denmark
View Trial Details
Active, Not Recruiting

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

NCT06008756

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +8 more
Locations
  • Advanced Cardiovascular - Alexander City ( Site 0156) Alexander City, Alabama, United States
  • Central Research Associates ( Site 0118) Birmingham, Alabama, United States
  • St. Vincent's Birmingham Hospital ( Site 0181) Birmingham, Alabama, United States
  • Central Alabama Research ( Site 0109) Birmingham, Alabama, United States
View all 669 locations
View Trial Details
Active, Not Recruiting

Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

NCT04579367

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +4 more
Locations
  • Dr. Armin Öhlinger Kardiologe & innere Medizin Dornbirn, Austria
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • LKH-Univ. Klinikum Graz Graz, Austria
  • Medizinische Universität Graz Graz, Austria
View all 443 locations
View Trial Details

Related conditions